Effect of adiponectin on ATDC5 proliferation, differentiation and signaling pathways

Molecular and Cellular Endocrinology

Volumn 323, Issue 2, 2010, Pages 282-291

  Challa, T Delessa ^a   Rais, Y ^a   Ornan, E Monsonego ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Adipocytokine; Adiponectin; ATDC5; Bone development; Chondrocyte

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; AGGRECAN; ALKALINE PHOSPHATASE; COLLAGEN TYPE 10; COLLAGEN TYPE 2; FIBROBLAST GROWTH FACTOR 18; FIBROBLAST GROWTH FACTOR 9; GELATINASE B; OSTEOGENIC PROTEIN 1; PROTEIN P21; PROTEIN PATCHED 1; PROTEOGLYCAN; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR RUNX2; BIOLOGICAL MARKER;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL STRAIN ATDC5; CHONDROGENESIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOGLYCAN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ZYMOGRAPHY; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ADIPONECTIN; AGGRECANS; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHONDROCYTES; CHONDROGENESIS; COLLAGEN TYPE II; COLLAGEN TYPE X; CORE BINDING FACTOR ALPHA 1 SUBUNIT; MATRIX METALLOPROTEINASE 9; MICE; RECEPTORS, ADIPONECTIN; SIGNAL TRANSDUCTION;

EID: 77952957668     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.03.025     Document Type: Article

References (60)

1. Altaf F.M., Hering T.M., Kazmi N.H., Yoo J.U., Johnstone B. Ascorbate-enhanced chondrogenesis of ATDC5 cells. Eur. Cell Mater. 2006, 12:64-69. discussion 69-70.
2. Atsumi T., Miwa Y., Kimata K., Ikawa Y. A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ. Dev. 1990, 30:109-116.
3. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 96:939-949.
4. Berner H.S., Lyngstadaas S.P., Spahr A., Monjo M., Thommesen L., Drevon C.A., Syversen U., Reseland J.E. Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004, 35:842-849.
5. Brochhausen C., Lehmann M., Halstenberg S., Meurer A., Klaus G., Kirkpatrick C.J. Signalling molecules and growth factors for tissue engineering of cartilage-what can we learn from the growth plate?. J. Tissue Eng. Regen. Med. 2009, 3:416-429.
6. Burdan F., Szumilo J., Korobowicz A., Farooquee R., Patel S., Patel A., Dave A., Szumilo M., Solecki M., Klepacz R., Dudka J. Morphology and physiology of the epiphyseal growth plate. Folia Histochem. Cytobiol. 2009, 47:5-16.
7. Chen T.H., Chen L., Hsieh M.S., Chang C.P., Chou D.T., Tsai S.H. Evidence for a protective role for adiponectin in osteoarthritis. Biochim. Biophys. Acta 2006, 1762:711-718.
8. Chiu Y.C., Shieh D.C., Tong K.M., Chen C.P., Huang K.C., Chen P.C., Fong Y.C., Hsu H.C., Tang C.H. Involvement of AdipoR receptor in adiponectin-induced motility and alpha2beta1 integrin upregulation in human chondrosarcoma cells. Carcinogenesis 2009, 30:1651-1659.
9. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996, 84:911-921.
10. Diez J.J., Estrada P., Bajo M.A., Fernandez-Reyes M.J., Grande C., del Peso G., Heras M., Molina A., Iglesias P., Sanchez-Villanueva R., Selgas R. High stable serum adiponectin levels are associated with a better outcome in prevalent dialysis patients. Am. J. Nephrol. 2009, 30:244-252.
11. Gomez R., Lago F., Gomez-Reino J., Dieguez C., Gualillo O. Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases. J. Mol. Endocrinol. 2009, 43:11-18.
12. Huang K.C., Chen C.L., Chuang L.M., Ho S.R., Tai T.Y., Yang W.S. Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J. Clin. Endocrinol. Metab. 2003, 88:4130-4134.
13. Johnstone E.W., Leane P.B., Kolesik P., Byers S., Foster B.K. Spatial arrangement of physeal cartilage chondrocytes and the structure of the primary spongiosa. J. Orthop. Sci. 2000, 5:294-301.
14. Kamoda T., Nozue H., Matsui A. Serum levels of adiponectin and IGFBP-1 in short children born small for gestational age. Clin. Endocrinol. (Oxf.) 2007, 66:290-294.
15. Karsenty G. The complexities of skeletal biology. Nature 2003, 423:316-318.
16. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2002, 2:389-406.
17. Kato Y., Iwamoto M. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J. Biol. Chem. 1990, 265:5903-5909.
18. Kirimoto A., Takagi Y., Ohya K., Shimokawa H. Effects of retinoic acid on the differentiation of chondrogenic progenitor cells, ATDC5. J. Med. Dent. Sci. 2005, 52:153-162.
19. Koerner A., Kratzsch J., Kiess W. Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come. Best Pract. Res. Clin. Endocrinol. Metab. 2005, 19:525-546.
20. Korner A., Bluher S., Kapellen T., Garten A., Klammt J., Kratzsch J., Kiess W. Obesity in childhood and adolescence: a review in the interface between adipocyte physiology and clinical challenges. Hormones (Athens) 2005, 4:189-199.
21. Kronenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
22. Kurth T., Hedbom E., Shintani N., Sugimoto M., Chen F.H., Haspl M., Martinovic S., Hunziker E.B. Chondrogenic potential of human synovial mesenchymal stem cells in alginate. Osteoarthritis Cartilage 2007, 15:1178-1189.
23. Lago R., Gomez R., Otero M., Lago F., Gallego R., Dieguez C., Gomez-Reino J.J., Gualillo O. A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage 2008, 16:1101-1109.
24. Lago F., Gomez R., Gomez-Reino J.J., Dieguez C., Gualillo O. Adipokines as novel modulators of lipid metabolism. Trends Biochem. Sci. 2009, 34:500-510.
25. Lee N.K., Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends Endocrinol. Metab. 2008, 19:161-166.
26. Lefebvre V., Smits P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res. C: Embryo Today 2005, 75:200-212.
27. Lenchik L., Register T.C., Hsu F.C., Lohman K., Nicklas B.J., Freedman B.I., Langefeld C.D., Carr J.J., Bowden D.W. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003, 33:646-651.
28. Luo X.H., Guo L.J., Yuan L.Q., Xie H., Zhou H.D., Wu X.P., Liao E.Y. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp. Cell Res. 2005, 309(1):99-109.
29. Maeda T., Jikko A., Abe M., Yokohama-Tamaki T., Akiyama H., Furukawa S., Takigawa M., Wakisaka S. Cartducin, a paralog of Acrp30/adiponectin, is induced during chondrogenic differentiation and promotes proliferation of chondrogenic precursors and chondrocytes. J. Cell. Physiol. 2006, 206:537-544.
30. Minina E., Kreschel C., Naski M.C., Ornitz D.M., Vortkamp A. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev. Cell 2002, 3:439-449.
31. Mohamed-Ali V., Pinkney J.H., Coppack S.W. Adipose tissue as an endocrine and paracrine organ. Int. J. Obes. Relat. Metab. Disord. 1998, 22:1145-1158.
32. Monsonego-Ornan E., Ben-Ami M. The role of leptin in bone development and growth. Landes Bioscience. Leptin and Leptin Antagonists 2008, 83-90.
33. Nakajima M., Negishi Y., Tanaka H., Kawashima K. p21(Cip-1/SDI-1/WAF-1) expression via the mitogen-activated protein kinase signaling pathway in insulin-induced chondrogenic differentiation of ATDC5 cells. Biochem. Biophys. Res. Commun. 2004, 320:1069-1075.
34. Negishi Y., Ui N., Nakajima M., Kawashima K., Maruyama K., Takizawa T., Endo H. p21Cip-1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro. J. Biol. Chem. 2001, 276:33249-33256.
35. Ohlsson C., Nilsson A., Isaksson O., Lindahl A. Growth hormone induces multiplication of the slowly cycling germinal cells of the rat tibial growth plate. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:9826-9830.
36. Ortega N., Behonick D., Stickens D., Werb Z. How proteases regulate bone morphogenesis. Ann. N. Y. Acad. Sci. 2003, 995:109-116.
37. Oshima K., Nampei A., Matsuda M., Iwaki M., Fukuhara A., Hashimoto J., Yoshikawa H., Shimomura I. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem. Biophys. Res. Commun. 2005, 331:520-526.
38. Reich A., Sharir A., Zelzer E., Hacker L., Monsonego-Ornan E., Shahar R. The effect of weight loading and subsequent release from loading on the postnatal skeleton. Bone 2008, 43:766-774.
39. Reich A., Simsa-Maziel S., Ashkenazi Z., Monsonego Ornan E. Involvement of matrix metalloproteinases in the growth plate response to physiological mechanical load. J. Appl. Physiol. 2010, 108(1):172-180.
40. Rockel J.S., Bernier S.M., Leask A. Egr-1 inhibits the expression of extracellular matrix genes in chondrocytes by TNFalpha-induced MEK/ERK signalling. Arthritis Res. Ther. 2009, 11:R8.
41. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 1995, 270:26746-26749.
42. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
43. Shinoda Y., Yamaguchi M., Ogata N., Akune T., Kubota N., Yamauchi T., Terauchi Y., Kadowaki T., Takeuchi Y., Fukumoto S., Ikeda T., Hoshi K., Chung U.I., Nakamura K., Kawaguchi H. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J. Cell. Biochem. 2006, 99:196-208.
44. Shukunami C., Shigeno C., Atsumi T., Ishizeki K., Suzuki F., Hiraki Y. Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J. Cell Biol. 1996, 133:457-468.
45. Shukunami C., Ishizeki K., Atsumi T., Ohta Y., Suzuki F., Hiraki Y. Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J. Bone Miner. Res. 1997, 12:1174-1188.
46. Shukunami C., Ohta Y., Sakuda M., Hiraki Y. Sequential progression of the differentiation program by bone morphogenetic protein-2 in chondrogenic cell line ATDC5. Exp. Cell Res. 1998, 241:1-11.
47. Simsa S., Hasdai A., Dan H., Ornan E.M. Differential regulation of MMPs and matrix assembly in chicken and turkey growth-plate chondrocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R2216-R2224.
48. Simsa S., Genina O., Monsonego Ornan E. Matrix metalloproteinase expression and localization in turkey (Meleagris gallopavo) during the endochondral ossification process. J. Anim. Sci. 2007, 85:1393-1401.
49. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., Armstrong D., Ducy P., Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002, 111:305-317.
50. Tong A., Reich A., Genin O., Pines M., Monsonego-Ornan E. Expression of chicken 75-kDa gelatinase B-like enzyme in perivascular chondrocytes suggests its role in vascularization of the growth plate. J. Bone Miner. Res. 2003, 18:1443-1452.
51. Ukkola O., Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities?. J. Mol. Med. 2002, 80:696-702.
52. van der Eerden B.C., Karperien M., Wit J.M. Systemic and local regulation of the growth plate. Endocr. Rev. 2003, 24:782-801.
53. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., Shapiro S.D., Senior R.M., Werb Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93:411-422.
54. Weizmann S., Tong A., Reich A., Genina O., Yayon A., Monsonego-Ornan E. FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossification. Matrix Biol. 2005, 24:520-529.
55. Williams G.A., Wang Y., Callon K.E., Watson M., Lin J.M., Lam J.B., Costa J.L., Orpe A., Broom N., Naot D., Reid I.R., Cornish J. In vitro and in vivo effects of adiponectin on bone. Endocrinology 2009, 150:3603-3610.
56. Yamashita S., Andoh M., Ueno-Kudoh H., Sato T., Miyaki S., Asahara H. Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp. Cell Res. 2009, 315:2231-2240.
57. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., Sugiyama T., Miyagishi M., Hara K., Tsunoda M., Murakami K., Ohteki T., Uchida S., Takekawa S., Waki H., Tsuno N.H., Shibata Y., Terauchi Y., Froguel P., Tobe K., Koyasu S., Taira K., Kitamura T., Shimizu T., Nagai R., Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769.
58. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., Chen C.L., Tai T.Y., Chuang L.M. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 2001, 86:3815-3819.
59. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., Kihara S., Funahashi T., Tenner A.J., Tomiyama Y., Matsuzawa Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96:1723-1732.
60. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.